Equities

Green Thumb Industries Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Green Thumb Industries Inc

Actions
  • Price (EUR)5.78
  • Today's Change0.00 / 0.00%
  • Shares traded100.00
  • 1 Year change-15.12%
  • Beta0.9201
Data delayed at least 15 minutes, as of Feb 16 2026 07:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Green Thumb Industries Inc. is a cannabis consumer packaged goods company. The Company is a retailer, which promotes well-being through the power of cannabis while giving back to the communities in which it serves. It has two segments: Retail and Consumer Packaged Goods. The Company manufactures and distributes a portfolio of branded cannabis products including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles and RHYTHM, to third-party retail stores across the United States as well as to Green Thumb owned retail stores. The Company also owns and operates a national chain of retail cannabis stores under the brand name of RISE Dispensary, as well as retail stores operating under other names. It has over 20 manufacturing facilities, 101 open retail locations and operations across 14 United States markets, including California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia.

  • Revenue in CAD (TTM)1.58bn
  • Net income in CAD59.41m
  • Incorporated2006
  • Employees4.80k
  • Location
    Green Thumb Industries Inc325 WEST HURON STREET, SUITE 700CHICAGO 60654United StatesUSA
  • Phone+1 (312) 471-6720
  • Fax+1 (604) 684-6242
  • Websitehttps://www.gtigrows.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.